Skip to main content
Professional Technical IVT

cytoreductive surgery

Pronunciation: SY-toe-ree-DUK-tiv

Surgical procedure aimed at removing as much visible tumor as possible, typically in advanced or metastatic disease.

Full Definition

Cytoreductive surgery, also known as debulking surgery, involves the aggressive surgical removal of all visible tumor deposits with the goal of achieving optimal cytoreduction. This approach is most commonly employed in peritoneal carcinomatosis from ovarian, colorectal, or appendiceal primaries, and may be combined with hyperthermic intraperitoneal chemotherapy (HIPEC). The success of cytoreductive surgery is often measured by the completeness of cytoreduction score, with optimal debulking defined as residual tumor nodules less than 1cm in diameter. This complex procedure requires extensive surgical expertise and careful patient selection, as it carries significant perioperative morbidity but may offer survival benefits in appropriately selected patients.

Usage

Usage note: Often used interchangeably with debulking surgery, though cytoreductive implies more aggressive approach.

In Context

  • "The patient underwent extensive cytoreductive surgery achieving CC-1 completeness of cytoreduction." — Operative report
  • "Multidisciplinary review recommended cytoreductive surgery followed by HIPEC for the peritoneal carcinomatosis." — Treatment planning documentation

Also known as

debulking surgery tumor debulking

Contrasted with

R0 resection complete resection

Don't confuse with

curative resection palliative resection

Editors from these organisations have used our services since 1998

Reuters BBC Oxford University Press Penguin Random House Springer Microsoft Suncor Energy United Nations Fisher Investments IBM The Home Depot KODAK CHEVRON